spacer
home > pmps > winter 2001 > an introduction to transdermal drug delivery systems
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

An Introduction to Transdermal Drug Delivery Systems

In the first part of this article in the Autumn 2001 issue of PMPS, we analysed the varieties, the structure and the basic components of patches. This 'promenade' was important in order to better understand how these drug delivery systems are composed. In this second part we will follow the processes involved in the production of the two major classes, matrix and liquid reservoir patches. We will then finish with a detailed description of the whole production chain for the most popular class at present - the matrix systems.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Spyridon A. Fotinos, Executive Vice President - Corporate Research & Innovation, at Lavipharm Group of Companies
Spyridon Fotinos studied pharmaceutics at the University of Athens, before going on to study chemistry at the University of Thessaloniki. He joined Lavipharm in 1979, and in 1987, established the Research and Development Department, of which he has since become a Director.
Spyridon's current position is Executive Vice President - Corporate Research and Innovation. Prior to his time at Lavipharm, he served for four years as Director of Planning and Studies at Minerva Pharmaceuticals. Spyridon is a patent holder in the areas of pharmaceutical and cosmetic delivery technology, antioxidant and enzymic systems. He is also a member of several Greek and international scientific organisations.

spacer
Spyridon A. Fotinos
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Signant Health finds growing eConsent adoption forecasts and the importance of eClinical integration in latest “State of eConsent” survey

PHILADELPHIA, PA – January 16, 2020: Signant Health, released the findings from its latest “State of eConsent” report today, highlighting the sentiments, successes, and challenges of eConsent practitioners around the world. Join Signant Health’s webinar on February 12, 2020 at 11am ET or 3pm ET to learn more about the findings.
More info >>

White Papers

Pharmaceutical Companies: Outsourcing Combination Product Manufacturing

Phillips-Medisize

Combination products are therapeutics that combine two or more products (drug/device, biologics/device, biologics/drugs, or drug/device/biologics), regulated and sold as a single unit. Examples of combination products include drug-coated implantable devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
More info >>

 
Industry Events

2020 Avoca Quality and Innovation Summit

3-4 June 2020, Amsterdam, The Netherlands

The 2020 Avoca Quality and Innovation Summit will take place 3-4 June 2020, in Amsterdam, The Netherlands.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement